Clinical Trial Update: A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of on-demand rabeprazole maintenance therapy for non-erosive reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Non-erosive Reflux Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Gastroesophageal Reflux, Heartburn | Phase 3 | Status: COMPLETED